Jonathan Corren, MD - Reducing the Burden of Chronic Rhinosinusitis With Nasal Polyps on Patient Quality of Life: An Exploration of Novel and Emerging Biologic Therapy

Go online to PeerView.com/XNY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in chronic rhinosinusitis with nasal polyps discusses novel and emerging biologic therapies to improve the quality of life for patients with chronic rhinosinusitis with nasal polyps. Upon completion of this activity, participants should be better able to: Recognize the burden that chronic rhinosinusitis with nasal polyps (CRS/NP) on patient quality of life, Describe the pathophysiology of CRS/NP and its relevance to novel therapeutic targets, Assess the latest clinical evidence regarding efficacy and safety for available and emerging treatments for CRS/NP, Apply individualized treatment plans, including the use of targeted biologic therapy, for patients with CRS/NP inadequately controlled on standard therapy.